← Back to Search

Dementia Care Training for Dementia (CfAA Trial)

N/A

Waitlist Available

Led By Olivia I Okereke, MD, MS

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Mild cognitive impairment or dementia diagnosis of no greater than mild-moderate severity

Age 60 years and above

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

CfAA Trial Summary

This trial will test if improved training for home health aides can reduce behavioral symptoms and improve life quality for people with dementia and their care partners.

Who is the study for?

This trial is for individuals aged 60 or above with mild to moderate dementia or cognitive impairment, who are part of the Mass General Brigham healthcare system and have a care partner. They must be referred to home care services after hospital discharge and able to read English. Those with severe dementia, without a care partner, in palliative care, or unable to consent due to cognitive issues cannot participate.Check my eligibility

What is being tested?

The study tests if special training for home health aides on how to handle dementia can improve behavior symptoms in older adults with dementia/cognitive impairment and enhance life quality for them and their caregivers. Participants will be randomly assigned into groups receiving either enhanced training or standard practices.See study design

What are the potential side effects?

Since this intervention involves educational training rather than medication, traditional side effects are not expected. However, there may be indirect effects on patients' well-being based on changes in caregiver behavior following the training.

CfAA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cognitive issues are mild to moderate.

Select...

I am 60 years old or older.

CfAA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Neuropsychiatric Inventory-Questionnaire

Patient-Reported Outcomes Measurement Information System Global Health, 10-item

CfAA Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Home Health Aides with Enhanced Curriculum TrainingExperimental Treatment1 Intervention

The enhanced curriculum of 108 hours of home health aide (HHA) training will constitute the Experimental arm. This arm consists of the 100 hours of the standard curriculum plus an 8-hour enhanced curriculum that includes additional didactic content and a skills practicum on dementia and recognizing and responding to dementia-related behaviors. As with the standard curriculum, the enhanced curriculum will be delivered by the training entity, CCHERS (Center for Community Health Education, Research and Service, Inc.). The enhanced component is delivered over an additional 2 instructional days (10% increase in instructional days from the standard curriculum).

Group II: Home Health Aides with Standard Curriculum TrainingActive Control1 Intervention

The standard curriculum of 100 hours of home health aide (HHA) training will constitute the No Intervention arm. This 100-hour training is the standard curriculum that has been used by the training entity, CCHERS (Center for Community Health Education, Research and Service, Inc.), for many years to qualify HHAs to receive certificates from the Massachusetts Home Care Aide Council. The standard curriculum includes 75 hours of basic instruction ("ABC's for Direct Care Workers") and 25 hours of additional content on mental health and dementia topics. The standard curriculum is delivered over approximately on month, or 20 instructional days.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,235 Total Patients Enrolled

25 Trials studying Dementia

202,453 Patients Enrolled for Dementia

Olivia I Okereke, MD, MSPrincipal InvestigatorMassachusetts General Hospital

Olivia I OkerekePrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively recruiting participants?

"It appears that this clinical trial is no longer enrolling patients, as the last update on clinicaltrials.gov was made on August 28th 2023. However, there are still 1363 other medical studies searching for participants in total."

Answered by AI

Recent research and studies

Journal of Clinical EpidemiologyJournal

The Patient-reported Outcomes Measurement Information System (PROMIS) Developed and Tested Its First Wave of Adult Self-reported Health Outcome Item Banks: 2005–2008

Cella, David, William Riley, Arthur Stone, Nan Rothrock, Bryce Reeve, Susan Yount, Dagmar Amtmann, et al.. 2010. “The Patient-reported Outcomes Measurement Information System (PROMIS) Developed and Tested Its First Wave of Adult Self-reported Health Outcome Item Banks: 2005–2008”. Journal of Clinical Epidemiology. Elsevier BV. doi:10.1016/j.jclinepi.2010.04.011.

clinicaltrials.govStudy

The Care for America's Aging Study

Olivia I.Okereke, MD 2024. "The Care for America's Aging Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06021704.